Late pregnancy bleeding

American Family Physician

Volumn 75, Issue 8, 2007, Pages 1199-1206

  Sakornbut, Ellen ^a,b   Leeman, Lawrence ^c,d   Fontaine, Patricia ^e  

^a Family Health Center of Waterloo   (United States)

^b School of Medicine ^*

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; MAGNESIUM SULFATE;

CLINICAL FEATURE; ECHOGRAPHY; FLUID RESUSCITATION; HUMAN; PLACENTA PREVIA; PREGNANCY DISORDER; REVIEW; RISK FACTOR; SOLUTIO PLACENTAE; THIRD TRIMESTER PREGNANCY; VAGINA BLEEDING;

ALGORITHMS; FEMALE; HUMANS; PLACENTA DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, THIRD; ULTRASONOGRAPHY, PRENATAL; UTERINE HEMORRHAGE;

EID: 34247371850     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Chilaka VN, Konje JC, Clarke S, Taylor DJ. Practice observed: is speculum examination on admission a necessary procedure in the management of all cases of antepartum haemorrhage? J Obstet Gynaecol 2000;20:396-8.
2. Prevention of Rh D alloimmunization. ACOG Practice Bulletin No. 4, May 1999. Clinical management guidelines for obstetrician-gynecologists. American College of Obstetrics and Gynecology. Int J Gynaecol Obstet 1999;66:63-70.
3. Royal College of Obstetricians and Gynaecologists (RCOG). The use of electronic fetal monitoring. The use and interpretation of cardiotocography in intrapartum fetal surveillance. Evidence-based clinical guidelines No. 8. London: RCOG, 2001.
4. Bhide A, Prefumo F, Moore J, Hollis B, Thilaganathan B. Placental edge to internal os distance in the late third trimester and mode of delivery in placenta praevia. BJOG 2003;110:860-4.
5. Bhide A, Thilaganathan B. Recent advances in the management of placenta previa. Curr Opin Obstet Gynecol 2004;16:447-51.
6. Faiz AS, Ananth CV. etiology and risk factors for placenta previa: an overview and meta-analysis of observational studies. J Matern Fetal Neonatal Med 2003;13:175-90.
7. Clark SL, Koonings PP, Phelan JP. Placenta previa/accreta and prior cesarean section. Obstet Gynecol 1985;66:89-92.
8. Hladky K, Yankowitz J, Hansen WF. Placental abruption. Obstet Gynecol Surv 2002;57:299-305.
9. Ananth CV, Oyelese Y, Yeo L, Pradhan A, Vintzileos AM. Placental abruption in the United States, 1979 through 2001: temporal trends and potential determinants. Am J Obstet Gynecol 2005;192:191-8.
10. Fleming AD. Abruptio placentae. Crit Care Clin 1991;7:865-75.
11. Oyalese KO, Turner M, Lees C, Campbell S. Vasa previa: an avoidable obstetric tragedy. Obstet Gynecol Surv 1999;54:138-45.
12. Mustafa SA, Brizot ML, Carvalho MH, Watanabe L, Kahhale S, Zugaib M. Transvaginal ultrasonography in predicting placenta previa at delivery: a longitudinal study. Ultrasound Obstet Gynecol 2002;20:356-9.
13. Smith RS, Lauria MR, Comstock CH, Treadwell MC, Kirk JS, Lee W, et al. Transvaginal ultrasonography for all placentas that appear to be low-lying or over the internal cervical os. Ultrasound Obstet Gynecol 1997;9:22-4.
14. Timor-Tritsch IE, Yunis RA. Confirming the safety of transvaginal sonography in patients suspected of placenta previa. Obstet Gynecol 1993;81(5 pt 1):742-4.
15. Royal College of Obstetricians and Gynaecologists (RCOG). Placenta praevia and placenta praevia accreta: diagnosis and management. Guideline No. 27. London: RCOG, 2005.
16. Cotton DB, Read JA, Paul RH, Quilligan EJ. The conservative aggressive management of placenta previa. Am J Obstet Gynecol 1980:137:687-95.
17. Sharma A, Suri V, Gupta I. Tocolytic therapy in conservative management of symptomatic placenta previa. Int J Gynaecol Obstet 2004;84:109-13.
18. Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev 2000;(2):CD000065.
19. Neilson JP. Interventions for suspected placenta previa. Cochrane Database Syst Rev 2003;(2):CD001998.
20. Wing DA, Paul RH, Millar LK. Management of the symptomatic placenta previa: a randomized, controlled trial of inpatient versus outpatient expectant management. Am J Obstet Gynecol 1996;175(4 pt 1):806-11.
21. Cobo E, Conde-Agudelo A, Delgado J, Canaval H, Congote A. Cervical cerclage: an alternative for the management of placenta previa? Am J Obstet Gynecol 1998;179:122-5.
22. Dashe JS, McIntire DD, Ramus RM, Santos-Ramos R, Twickler DM. Persistence of placenta previa according to gestational age at ultrasound detection. Obstet Gynecol 2002;99(5 pt 1):692-7.
23. Taipale P, Hiilesmaa V, Ylostalo P. Transvaginal ultrasonography at 18-23 weeks in predicting placenta previa at delivery. Ultrasound Obstet Gynecol 1998;12:422-5.
24. Becker RH, Vonk R, Mende BC, Ragosch V, entezami M. The relevance of placental location at 20-23 gestational weeks for prediction of placenta previa at delivery: evaluation of 8650 cases. Ultrasound Obstet Gynecol 2001;17:496-501.
25. National Collaborating Centre for Women's and Children's Health. Antenatal care: routine care for the healthy pregnant woman. Clinical Guideline. London: RCOG, 2003.
26. Comstock CH, Love JJ Jr, Bronsteen RA, Lee W, Vettraino IM, Huang RR, et al. Sonographic detection of placenta accreta in the second and third trimesters of pregnancy. Am J Obstet Gynecol 2004;190:1135-40.
27. Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol 2005;192:1458-61.
28. ACOG Committee on Obstetric Practice. Placenta accreta. ACOG Committee opinion No. 266, January 2002. Obstet Gynecol 2002;99:169-70.
29. Rasmussen S, Irgens LM, Bergsjo P, Dalaker K. The occurrence of placental abruption in Norway 1967-1991. Acta Obstet Gynecol Scand 1996;75:222-8.
30. Ananth CV, Berkowitz GS, Savitz DA, Lapinski RH. Placental abruption and adverse perinatal outcomes. JAMA 1999;282:1646-51.
31. Witlin AG, Sibai BM. Perinatal and maternal outcome following abruptio placentae. Hypertens Pregnancy 2001;20:195-203.
32. Neilson JP. Interventions for treating placental abruption. Cochrane Database Syst Rev 2003;(1):CD003247.
33. Knab DR. Abruptio placentae: an assessment of the time and method of delivery. Obstet Gynecol 1978;52:625-9.
34. Glantz C, Purnell L. Clinical utility of sonography in the diagnosis and treatment of placental abruption. J Ultrasound Med 2002;21:837-40.
35. Towers CV, Pircon RA, Heppard M. Is tocolysis safe in the management of third-trimester bleeding? Am J Obstet Gynecol 1999;180(6 pt 1):1572-8.
36. Kayani SI, Walkinshaw SA, Preston C. Pregnancy outcome in severe placental abruption. BJOG 2003;110:679-83.
37. Burton R, Belfort MA. etiology and management of hemorrhage. In: Dildy GA, Belfort MA, Saade GR, Phelan JP, Hankins GD, Clark SL, eds. Critical Care Obstetrics. 4th ed. Malden, Mass.: Blackwell Science, 2004:298-311.
38. Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J, et al., for the Magpie Trial Collaborative Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002;359:1877-90.
39. Nelle M, Zilow EP, Kraus M, Bastert G, Linderkamp O. The effect of Leboyer delivery on blood viscosity and other hemorheologic parameters in term neonates. Am J Obstet Gynecol 1993;169:189-93.
40. Apt L, Downey WS Jr. Melena neonatorum: the swallowed blood syndrome; a simple test for the differentiation of adult and fetal hemoglobin in bloody stools. J Pediatr 1955;47:6-12.
41. Oyelese Y, Catanzarite V, Prefumo F, Lashley S, Schachter M, Tovbin Y, et al. Vasa previa: the impact of prenatal diagnosis on outcomes. Obstet Gynecol 2004;103(5 pt 1):937-42.
42. Lee W, Lee VL, Kirk JS, Sloan CT, Smith RS, Comstock CH. Vasa previa: prenatal diagnosis, natural evolution, and clinical outcome. Obstet Gynecol 2000;95:572-6.